INR 449.05
(0.28%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 3.32 Billion INR | -0.38% |
2022 | 3.34 Billion INR | 419.03% |
2021 | 643.87 Million INR | 4.63% |
2020 | 615.37 Million INR | -51.31% |
2019 | 1.26 Billion INR | 29.24% |
2018 | 977.85 Million INR | 22.7% |
2017 | 796.94 Million INR | 40.71% |
2016 | 566.39 Million INR | 33.11% |
2015 | 425.51 Million INR | 29.66% |
2014 | 328.16 Million INR | -1.76% |
2013 | 334.04 Million INR | -3.99% |
2012 | 347.93 Million INR | 70.39% |
2011 | 204.2 Million INR | 10.71% |
2010 | 184.44 Million INR | 5.32% |
2009 | 175.12 Million INR | 15.68% |
2008 | 151.38 Million INR | -7.39% |
2007 | 163.46 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 FY | 3.32 Billion INR | -0.38% |
2023 Q2 | 3.58 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 3.32 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2022 FY | 3.34 Billion INR | 419.03% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 1.85 Billion INR | 0.0% |
2022 Q4 | 3.34 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 Q4 | 643.87 Million INR | 0.0% |
2021 FY | 643.87 Million INR | 4.63% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 353.16 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q2 | 1.27 Billion INR | 0.0% |
2020 FY | 615.37 Million INR | -51.31% |
2020 Q4 | 615.37 Million INR | 0.0% |
2019 Q4 | 1.26 Billion INR | 0.0% |
2019 Q2 | 1.13 Billion INR | 0.0% |
2019 FY | 1.26 Billion INR | 29.24% |
2018 Q4 | 977.85 Million INR | 0.0% |
2018 Q2 | 908.71 Million INR | 0.0% |
2018 FY | 977.85 Million INR | 22.7% |
2017 Q4 | 796.94 Million INR | 0.0% |
2017 FY | 796.94 Million INR | 40.71% |
2017 Q2 | 744.55 Million INR | 0.0% |
2016 Q4 | 566.39 Million INR | 0.0% |
2016 FY | 566.39 Million INR | 33.11% |
2016 Q2 | 420.87 Million INR | 0.0% |
2015 Q2 | 352.66 Million INR | 0.0% |
2015 Q4 | 425.51 Million INR | 0.0% |
2015 FY | 425.51 Million INR | 29.66% |
2014 Q2 | 275.66 Million INR | 0.0% |
2014 FY | 328.16 Million INR | -1.76% |
2014 Q4 | 328.16 Million INR | 0.0% |
2013 Q4 | 334.04 Million INR | 0.0% |
2013 FY | 334.04 Million INR | -3.99% |
2013 Q2 | 326.34 Million INR | 0.0% |
2012 Q4 | 347.93 Million INR | 0.0% |
2012 FY | 347.93 Million INR | 70.39% |
2011 Q4 | 204.2 Million INR | 0.0% |
2011 FY | 204.2 Million INR | 10.71% |
2010 FY | 184.44 Million INR | 5.32% |
2009 FY | 175.12 Million INR | 15.68% |
2008 FY | 151.38 Million INR | -7.39% |
2007 FY | 163.46 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Ajanta Pharma Limited | 352.8 Million INR | -843.639% |
Amrutanjan Health Care Limited | 17.28 Million INR | -19162.611% |
Sigachi Industries Limited | 1.43 Billion INR | -132.724% |
Bal Pharma Limited | 1.39 Billion INR | -138.396% |
Ind-Swift Laboratories Limited | 166.21 Million INR | -1902.91% |
Medico Remedies Limited | 80.5 Million INR | -4035.393% |
Lasa Supergenerics Limited | 220.76 Million INR | -1408.03% |
Venus Remedies Limited | 413.3 Million INR | -705.506% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -444.425% |
Alpa Laboratories Limited | 52.46 Million INR | -6245.482% |
Nectar Lifesciences Limited | 6.35 Billion INR | 47.617% |
Shilpa Medicare Limited | 9.37 Billion INR | 64.485% |
Aarti Drugs Limited | 5.64 Billion INR | 41.001% |
Lupin Limited | 29.21 Billion INR | 88.606% |
Aurobindo Pharma Limited | 66.47 Billion INR | 94.992% |
Zydus Lifesciences Limited | 8.04 Billion INR | 58.603% |
Windlas Biotech Limited | 36.41 Million INR | -9043.524% |
Suven Life Sciences Limited | 7.09 Million INR | -46809.356% |
Eris Lifesciences Limited | 27.81 Billion INR | 88.03% |
Valiant Laboratories Limited | 767.08 Million INR | -334.002% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 11.848% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 67.087% |
Ipca Laboratories Limited | 14.38 Billion INR | 76.854% |
Bliss GVS Pharma Limited | 998.4 Million INR | -233.449% |
Achyut Healthcare Limited | - INR | -Infinity% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 89.831% |
Bajaj HealthCare Limited | 3.32 Billion INR | -0.027% |
RPG Life Sciences Limited | - INR | -Infinity% |
Mankind Pharma Limited | 2.07 Billion INR | -60.695% |
Laurus Labs Limited | 25.77 Billion INR | 87.083% |
Piramal Pharma Limited | 47.1 Billion INR | 92.932% |
Syncom Formulations (India) Limited | 724.86 Million INR | -359.279% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 91.723% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 35.124% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 72.954% |
Unichem Laboratories Limited | 2.47 Billion INR | -34.504% |
Sequent Scientific Limited | 4.87 Billion INR | 31.737% |
Novartis India Limited | 69.7 Million INR | -4676.409% |
Wanbury Limited | 1.16 Billion INR | -185.802% |
Suven Pharmaceuticals Limited | 649.96 Million INR | -412.206% |
Wockhardt Limited | 23.56 Billion INR | 85.869% |
Themis Medicare Limited | 957.92 Million INR | -247.539% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -3623.473% |
Jubilant Pharmova Limited | 36.64 Billion INR | 90.914% |
Glenmark Life Sciences Limited | 171.48 Million INR | -1841.426% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 83.371% |
Divi's Laboratories Limited | 30 Million INR | -10997.19% |
NATCO Pharma Limited | 3.71 Billion INR | 10.314% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -916.226% |
Ind-Swift Limited | 10.13 Billion INR | 67.168% |
Procter & Gamble Health Limited | 95.6 Million INR | -3382.382% |
FDC Limited | 205.18 Million INR | -1522.515% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -72.112% |
Granules India Limited | 13.15 Billion INR | 74.684% |
Medicamen Biotech Limited | 308.17 Million INR | -980.292% |
Alkem Laboratories Limited | 14.18 Billion INR | 76.529% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -7140.131% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -75752.29% |
Brooks Laboratories Limited | 56.41 Million INR | -5800.773% |
Megasoft Limited | 1.47 Billion INR | -126.401% |
ZIM Laboratories Limited | 1.08 Billion INR | -205.92% |
Strides Pharma Science Limited | 25.16 Billion INR | 86.773% |
Neuland Laboratories Limited | 953.89 Million INR | -249.006% |
Morepen Laboratories Limited | 289.99 Million INR | -1048.017% |
Hikal Limited | 8.17 Billion INR | 59.28% |
Indoco Remedies Limited | 6.71 Billion INR | 50.456% |
Aarti Pharmalabs Limited | 2.85 Billion INR | -16.71% |
Kilitch Drugs (India) Limited | 316.46 Million INR | -951.983% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | -238.011% |
Hester Biosciences Limited | 2.44 Billion INR | -36.23% |